Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
123 participants
INTERVENTIONAL
2015-02-06
2033-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
NCT06569602
Feasibility Study of a Percutaneous Mitral Valve Repair System.
NCT00209339
TRISCEND II Pivotal Trial
NCT04482062
Pivotal Study of a Percutaneous Mitral Valve Repair System
NCT00209274
Mitral Valve Replacement With MValve Dock and Lotus
NCT02719912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Treatment with the Edwards EVOQUE Eos mitral valve replacement system
Edwards EVOQUE Eos Mitral Valve Replacement System
Replacement of the mitral valve through a transcatheter approach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Edwards EVOQUE Eos Mitral Valve Replacement System
Replacement of the mitral valve through a transcatheter approach
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High risk for open-heart surgery
* Meets anatomical criteria
Exclusion Criteria
* Patient is inoperable
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajendra Makkar, MD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center, Los Angeles, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sutter Mills-Peninsula
Burlingame, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Kaiser Permanente San Francisco
San Francisco, California, United States
Emory University Hospital/Emory University Hospital Midtown
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
St. Vincent Heart Center
Indianapolis, Indiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Morristown Medical Center
Morristown, New Jersey, United States
St. Francis Hospital
Roslyn, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
The University of Texas Health Science Center at Houston/Memorial Hermann Texas Medical Center
Houston, Texas, United States
The Heart Hospital Baylor Plano
Plano, Texas, United States
Intermountain Medical Center
Murray, Utah, United States
University of Virginia Health System
Charlottesville, Virginia, United States
St. Paul's Hospital
Vancouver, British Columbia, Canada
Institut Universitaire de Cardiologie et de Pneumologie de Quebec-Université Laval
Québec, , Canada
St. Michael's Hospital
Toronto, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-05C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.